Difference between revisions of "Loricrin (TG3)"
m |
|||
| Line 5: | Line 5: | ||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Loricrin |
|- | |- | ||
| Synonyms | | Synonyms | ||
Revision as of 15:24, 17 August 2007
| Template:Infobox header| Loricrin (TG3) | |
|---|---|
| Loricrin (TG3) | |
| Substrate peptide name | Loricrin |
| Synonyms | - |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | P23490 |
| Reactive glutamines | Q3, Q6, Q10, Q153, Q156, Q215, Q216, Q219, Q225, Q303, Q305, Q306, Q308 |
| Reactive lysines | K4, K5, K88, K307, K315 |
| Substrate sequence | SYQKKQPTPQPPV
SGGSVKYSGGG FSGQAVQCQSY YVSSQQVTQTSCA APQPSYGGG CHQTQQKQAPTWPSK |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:2007607 |
| Notes | Residues in bold have been determined as in situ substrates of TG3 |
| Template:Infobox header | | |
.png){kind=link}